Cigna Corp (CI)
$161.29
8.25 (4.87%)
CI Stock Quote Delayed 20 Minutes
Previous Close
$161.29
Market Cap
39.24B
PE Ratio
15.83
EPS
10.19
Volume (Avg. Vol.)
3.56M
Day's Range
159.80 - 167.79
52-Week Range
118.50 - 224.64
Dividend & Yield
0.04 (0.02%)
CI Stock Predictions, Articles, and Cigna Corp News
Stock Market Today: Tesla Scorches to New Highs; Buy Nike?
Tesla ripped to new highs and Nike's been named a Top Pick. Here's what else happened in the stock market today.
Healthcare Stocks: 1 Buy, 1 Sell, 1 Hold
You don't need to avoid healthcare stocks completely. Just be careful where you invest. There's one name Louis Navellier really likes in the space, for example.
Nasdaq Today: Biotech Wrecked; Buy Microsoft?
Investors saw new highs in the Nasdaq today, but the index finished slightly lower on the day. Here's what we're watching now.
4 Top Stock Trades for Friday: CGC, MU, BBBY
Cigna, Bed Bath & Beyond, Micron and Canopy Growth were our top stock trades on Thursday as we go into Friday.
CVS Stock Has More Going for It Than Just a 3.69% Dividend Yield
A judge is challenging the CVS Health-Aetna deal and the drug store sector is out of favor. So when will the discount on CVS stock end?
Aetna Uncertainty Is Keeping CVS Stock Way Undervalued
It admittedly takes some guts to step into CVS stock here, in the middle of a renewed legal mess, but that's exactly the time to go bargain hunting.
There’s a Buy the Dip Opportunity in Walgreens Stock but It Isn’t Now
Walgreens stock tanked after the company reported weak second-quarter results and issued a light outlook, but there's opportunity here.
Cigna Earnings: CI Stock Takes a Hit on Poor Guidance
Cigna earnings for the fourth quarter of the year included poor 2019 guidance, sending CI stock falling on Friday.
Cigna’s Merger With Express Scripts Is Positive for Cigna Stock
Cigna stock will be boosted by the merger of Cigna and Express Scripts Holding Co. In the wake of the deal, CIT stock looks cheap.
What Cigna Investors Should Expect From Its Latest Victory
Cigna is one step closer to a buyout of ESRX after approval from the Department of Justice. Here's what CI stock investors should expect.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
